As of August 2026 Agomab Therapeutics has a market cap of NZ$1.24 Billion. This makes Agomab Therapeutics the world's 6964th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Aug 10th, 2026 the market cap of Agomab Therapeutics was reported to be: